Truist Financial Corp Emergent Bio Solutions Inc. Transaction History
Truist Financial Corp
- $62.7 Billion
- Q4 2024
A detailed history of Truist Financial Corp transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Truist Financial Corp holds 85,193 shares of EBS stock, worth $667,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,193
Previous 144,196
40.92%
Holding current value
$667,913
Previous $1.2 Million
32.39%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding EBS
# of Institutions
172Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$30.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$25.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$16.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$15.4 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$12.1 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $391M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...